Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | B3GALT4 | Human | (+)-schisandrin B | multiple interactions | ISO | B3galt4 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA] | CTD | PMID:31150632 | B3GALT4 | Human | (S)-amphetamine | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Dextroamphetamine results in decreased expression of B3GALT4 mRNA | CTD | PMID:16715494 | B3GALT4 | Human | 1,2,4-trimethylbenzene | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | pseudocumene results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | B3GALT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GALT4 mRNA | CTD | PMID:22298810 | B3GALT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of B3GALT4 mRNA | CTD | PMID:32109520 | B3GALT4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | B3galt4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GALT4 mRNA | CTD | PMID:21570461 | B3GALT4 | Human | 2,4-dinitrotoluene | affects expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of B3GALT4 mRNA | CTD | PMID:21346803 | B3GALT4 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | B3GALT4 | Human | 4,4'-sulfonyldiphenol | decreases methylation | ISO | B3galt4 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of B3GALT4 promoter | CTD | PMID:33297965 | B3GALT4 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | B3galt4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of B3GALT4 gene | CTD | PMID:31683443 | B3GALT4 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of B3GALT4 mRNA | CTD | PMID:23724009 and PMID:33167477 | B3GALT4 | Human | ammonium chloride | affects expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of B3GALT4 mRNA | CTD | PMID:16483693 | B3GALT4 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of B3GALT4 mRNA | CTD | PMID:33212167 | B3GALT4 | Human | benzalkonium chloride | affects response to substance | EXP | | 6480464 | B3GALT4 SNP affects the susceptibility to Benzalkonium Compounds | CTD | PMID:27258892 | B3GALT4 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of B3GALT4 exon and Benzo(a)pyrene results in increased methylation of B3GALT4 promoter | CTD | PMID:27901495 | B3GALT4 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of B3GALT4 mRNA | CTD | PMID:25047013 | B3GALT4 | Human | bisphenol A | increases expression | ISO | B3galt4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of B3GALT4 mRNA | CTD | PMID:32156529 | B3GALT4 | Human | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of B3GALT4 gene | CTD | PMID:31601247 | B3GALT4 | Human | bisphenol A | increases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of B3GALT4 mRNA | CTD | PMID:34947998 | B3GALT4 | Human | bisphenol A | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of B3GALT4 mRNA | CTD | PMID:30816183 and PMID:32528016 | B3GALT4 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of B3GALT4 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 and PMID:31601247 | B3GALT4 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | B3GALT4 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 and PMID:26079696 | B3GALT4 | Human | cadmium dichloride | decreases methylation | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of B3GALT4 promoter | CTD | PMID:22457795 | B3GALT4 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | B3GALT4 | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | B3GALT4 | Human | choline | multiple interactions | ISO | B3galt4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | B3GALT4 | Human | cisplatin | affects response to substance | EXP | | 6480464 | B3GALT4 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | B3GALT4 | Human | cobalt dichloride | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of B3GALT4 mRNA | CTD | PMID:24386269 | B3GALT4 | Human | cypermethrin | increases expression | ISO | B3galt4 (Mus musculus) | 6480464 | cypermethrin results in increased expression of B3GALT4 mRNA | CTD | PMID:29020013 | B3GALT4 | Human | deoxynivalenol | decreases expression | EXP | | 6480464 | deoxynivalenol results in decreased expression of B3GALT4 mRNA | CTD | PMID:26763390 | B3GALT4 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | B3GALT4 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of B3GALT4 mRNA | CTD | PMID:37042841 | B3GALT4 | Human | folic acid | multiple interactions | ISO | B3galt4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | B3GALT4 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of B3GALT4 gene | CTD | PMID:31601247 | B3GALT4 | Human | heptanal | decreases expression | EXP | | 6480464 | heptanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | B3GALT4 | Human | hexanal | decreases expression | EXP | | 6480464 | n-hexanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | B3GALT4 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA | CTD | PMID:28628672 | B3GALT4 | Human | L-methionine | multiple interactions | ISO | B3galt4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALT4 mRNA | CTD | PMID:20938992 | B3GALT4 | Human | methamphetamine | multiple interactions | ISO | B3galt4 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | B3GALT4 | Human | methamphetamine | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | B3GALT4 | Human | naphthalenes | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Naphthalenes results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | B3GALT4 | Human | nitrogen dioxide | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of B3GALT4 gene | CTD | PMID:29935799 | B3GALT4 | Human | octanal | decreases expression | EXP | | 6480464 | caprylic aldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 | B3GALT4 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of B3GALT4 mRNA | CTD | PMID:26690555 | B3GALT4 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 and PMID:26079696 | B3GALT4 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of B3GALT4 mRNA | CTD | PMID:25014914 and PMID:26079696 | B3GALT4 | Human | SCH 23390 | multiple interactions | ISO | B3galt4 (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | B3GALT4 | Human | SCH 23390 | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | SCH 23390 results in decreased expression of B3GALT4 mRNA | CTD | PMID:19564919 | B3GALT4 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of B3GALT4 mRNA | CTD | PMID:25895662 | B3GALT4 | Human | Soman | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of B3GALT4 mRNA | CTD | PMID:19281266 | B3GALT4 | Human | succimer | multiple interactions | ISO | B3galt4 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of B3GALT4 mRNA | CTD | PMID:21641980 | B3GALT4 | Human | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of B3GALT4 mRNA | CTD | PMID:31838189 | B3GALT4 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of B3GALT4 mRNA | CTD | PMID:31533062 | B3GALT4 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | B3GALT4 | Human | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of B3GALT4 mRNA | CTD | PMID:21592394 | B3GALT4 | Human | tetrachloromethane | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA | CTD | PMID:31150632 | B3GALT4 | Human | tetrachloromethane | multiple interactions | ISO | B3galt4 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of B3GALT4 mRNA] | CTD | PMID:31150632 | B3GALT4 | Human | thioacetamide | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of B3GALT4 mRNA | CTD | PMID:34492290 | B3GALT4 | Human | titanium dioxide | decreases methylation | ISO | B3galt4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of B3GALT4 gene | CTD | PMID:35295148 | B3GALT4 | Human | trichloroethene | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of B3GALT4 mRNA | CTD | PMID:33387578 | B3GALT4 | Human | tungsten | increases expression | ISO | B3galt4 (Mus musculus) | 6480464 | Tungsten results in increased expression of B3GALT4 mRNA | CTD | PMID:30912803 | B3GALT4 | Human | undecane | decreases expression | ISO | B3galt4 (Rattus norvegicus) | 6480464 | undecane results in decreased expression of B3GALT4 protein | CTD | PMID:17337753 | B3GALT4 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of B3GALT4 gene | CTD | PMID:29154799 | B3GALT4 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of B3GALT4 mRNA | CTD | PMID:23527032 | B3GALT4 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of B3GALT4 mRNA | CTD | PMID:29154799 | B3GALT4 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of B3GALT4 mRNA | CTD | PMID:25979313 | |